Ovation Science Inc.

OVAT

CA69016D1087

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange Other stock markets 12:44:55 08/05/2024 am IST			5-day change	1st Jan Change
0.055 ^CAD	+22.22%		+22.22%	+57.14%

07/05	Ovation Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
11/04	Ovation Science Inc. Science Expands Market Reach with Exclusive Canadian License Agreement	CI

Ovation Science Inc. announced that it has received $0.05 million in funding

April 11, 2024

On April 11, 2024, Ovation Science Inc closed the transaction.

Latest news about Ovation Science Inc.

Ovation Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07/05	CI
Ovation Science Inc. Science Expands Market Reach with Exclusive Canadian License Agreement	11/04	CI
Ovation Science Inc. announced that it has received $0.05 million in funding	11/04	CI
Ovation Science Inc. announced that it expects to receive $0.05 million in funding	28/03	CI
Ovation Science Inc. announced that it expects to receive CAD 0.0675 million in funding	20/03	CI
Ovation Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11	CI
Ovation Science Inc. Signs License Agreement with Planet 13 Holdings, Inc	02/11	CI
Ovation Science Inc. Announces Executive Changes	30/23/30	CI
Ovation Science Inc. Announces Board Changes	30/23/30	CI
Ovation Science Inc. announced that it has received CAD 0.2 million in funding	12/23/12	CI
Ovation Science Inc. announced that it expects to receive CAD 0.2 million in funding	03/23/03	CI
Ovation Science Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29/23/29	CI
Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	30/23/30	CI
Ovation Science Inc. Signs Exclusive License Agreement for Its Topical Transdermal Cannabis Products for Pennsylvania	24/23/24	CI
Ovation Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01	CI
Ovation Science Announces International Supply and Distribution Agreement	28/23/28	CI
Ovation Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/22/29	CI
Ovation Science Inc. Significantly Expands its Topical/Transdermal Cannabis Product Distribution in Four US States	07/22/07	CI
Ovation Science Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	27/22/27	CI
Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	30/22/30	CI
Ovation Science Inc. Auditor Raises 'Going Concern' Doubt	02/22/02	CI
Ovation Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	02/22/02	CI
Ovation Science Develops New High Dose CBD Formulations for Health and Wellness, Beauty Lines	03/21/03	MT
Ovation Science Inc. Provides an Update on Its Topical Cannabis Research and Development Efforts	03/21/03	CI
Ovation Science Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	27/21/27	CI

Ovation Science Inc. is a Canada-based research and development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. It manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skin care products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers health and wellness products enhanced with hemp-derived CBD and delivered by patented Invisicare skin technology.

Sector

Biotechnology & Medical Research

Calendar

27/05/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Bio Medical Devices

	1st Jan change	Capi.
OVATION SCIENCE INC.	+57.14%	14.19L
MIMEDX GROUP, INC.	-9.92%	109.96Cr
NIBEC CO., LTD.	-23.00%	13Cr
COLLPLANT BIOTECHNOLOGIES LTD.	+2.74%	7.59Cr
KIM FOREST ENTERPRISE CO., LTD.	+2.44%	6Cr
BONUS BIOGROUP LTD.	-2.99%	5.08Cr

Bio Medical Devices